Home › Agent Hub › Agent Tools › Part D coverage by drug › Bevespi
Agent Tools
Bevespi is a brand of formoterol / glycopyrronium. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 1,743 of 5,492 Medicare Part D and Medicare Advantage drug plans (31.7%) list Bevespi on their formulary, across 79 of 286 formularies. The most common placement is tier 3 (1,411 plans, 81% of those covering it). 0 of the covering plans require prior authorization (0%), 10 step therapy and 1,740 a quantity limit.
176 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $42, 42 of them $0; 1,567 charge coinsurance instead — median 17% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 1,917 of 5,496 plans covered it (34.9%); 2027: 1,743 of 5,492 (31.7%).
Of 4,367 plans offered in both years, 11 added it to the formulary and 132 dropped it.
Among plans covering it both years, 13 moved it to a higher tier and 234 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 38 |
| Tier 2 | 272 |
| Tier 3 | 1,411 |
| Tier 4 | 22 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 72 of 323 | 22.3% | 0% |
| Medicare Advantage with drugs (MA-PD) | 967 of 3,200 | 30.2% | 0% |
| Special needs plans (SNP) | 704 of 1,969 | 35.8% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 0 of 846 | No tier listed | 0 |
| UnitedHealthcare | 0 of 830 | No tier listed | 0 |
| Devoted Health | 446 of 728 | Tier 3 | 0 |
| Aetna Medicare | 611 of 631 | Tier 3 | 0 |
| Wellcare | 268 of 268 | Tier 2 | 0 |
| HealthSpring | 0 of 226 | No tier listed | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 83 of 83 | Tier 3 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 0 of 80 | No tier listed | 0 |
| Alignment Health Plan | 0 of 77 | No tier listed | 0 |
| Anthem Blue Cross and Blue Shield | 0 of 74 | No tier listed | 0 |
| Wellpoint | 0 of 63 | No tier listed | 0 |
| Priority Health Medicare | 0 of 40 | No tier listed | 0 |
| CarePlus Health Plans, Inc. | 0 of 37 | No tier listed | 0 |
| Zing Health | 36 of 36 | Tier 3 | 0 |
| Capital Blue Cross | 0 of 35 | No tier listed | 0 |
| Prominence Health Plan | 0 of 29 | No tier listed | 0 |
| Medica | 1 of 27 | Tier 3 | 0 |
| Anthem HealthKeepers | 0 of 26 | No tier listed | 0 |
| Blue Cross Blue Shield of Michigan | 0 of 26 | No tier listed | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 46 of 114 | 40.4% |
| Alaska | 2 of 9 | 22.2% |
| American Samoa | 0 of 1 | 0% |
| Arizona | 54 of 147 | 36.7% |
| Arkansas | 36 of 85 | 42.4% |
| California | 121 of 397 | 30.5% |
| Colorado | 29 of 106 | 27.4% |
| Connecticut | 25 of 54 | 46.3% |
| Delaware | 14 of 43 | 32.6% |
| District of Columbia | 2 of 12 | 16.7% |
| Florida | 177 of 545 | 32.5% |
| Georgia | 44 of 149 | 29.5% |
| Guam | 0 of 1 | 0% |
| Hawaii | 19 of 50 | 38% |
| Idaho | 4 of 45 | 8.9% |
| Illinois | 58 of 132 | 43.9% |
| Indiana | 39 of 138 | 28.3% |
| Iowa | 24 of 64 | 37.5% |
| Kansas | 32 of 84 | 38.1% |
| Kentucky | 31 of 121 | 25.6% |
| Louisiana | 50 of 125 | 40% |
| Maine | 19 of 52 | 36.5% |
| Maryland | 17 of 49 | 34.7% |
| Massachusetts | 64 of 89 | 71.9% |
| Michigan | 43 of 182 | 23.6% |
| Minnesota | 11 of 63 | 17.5% |
| Mississippi | 43 of 104 | 41.3% |
| Missouri | 71 of 170 | 41.8% |
| Montana | 2 of 27 | 7.4% |
| Nebraska | 19 of 51 | 37.3% |
| Nevada | 24 of 100 | 24% |
| New Hampshire | 5 of 25 | 20% |
| New Jersey | 23 of 73 | 31.5% |
| New Mexico | 8 of 68 | 11.8% |
| New York | 88 of 215 | 40.9% |
| North Carolina | 52 of 176 | 29.5% |
| North Dakota | 5 of 26 | 19.2% |
| Northern Mariana Islands | 0 of 1 | 0% |
| Ohio | 59 of 171 | 34.5% |
| Oklahoma | 15 of 81 | 18.5% |
| Oregon | 24 of 92 | 26.1% |
| Pennsylvania | 67 of 323 | 20.7% |
| Puerto Rico | 17 of 64 | 26.6% |
| Rhode Island | 9 of 29 | 31% |
| South Carolina | 29 of 89 | 32.6% |
| South Dakota | 9 of 30 | 30% |
| Tennessee | 48 of 156 | 30.8% |
| Texas | 124 of 407 | 30.5% |
| U.S. Virgin Islands | 0 of 1 | 0% |
| Utah | 16 of 53 | 30.2% |
| Vermont | 4 of 14 | 28.6% |
| Virginia | 24 of 144 | 16.7% |
| Washington | 29 of 114 | 25.4% |
| West Virginia | 20 of 69 | 29% |
| Wisconsin | 16 of 96 | 16.7% |
| Wyoming | 2 of 13 | 15.4% |
Medicare Part D paid for 161,671 30-day fills of Bevespi in 2024 for about 31,168 enrollees, at an average total cost of $404.39 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Bevespi and the rest of a client's list on every plan in their county.
Estimate Bevespi costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.